Schedule Update - effective 1 June 2012 (text extract)

This is the text extract for Schedule Update - effective 1 June 2012, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 June 2012

Cumulative for May and June 2012 Section H cumulative for April, May and June 2012

Only

annually for hard copy Schedule and Updates

$55

www. schedule. co.nz

today

to receive electronic and/or hard copy

Contents

Summary of PHARMAC decisions effective 1 June 2012 ................................ 3 Changes to Pharmaceutical Schedule subscriptions ...................................... 4 Medicines moving to Stat dispensing ............................................................ 5 Varenicline Special Authority ......................................................................... 5 Change in subsidised brand for atorvastatin ................................................. 6 Risperidone and Quetiapine – up coming subsidy changes for July 2012 ...... 6 Metoprolol – up coming sole supply ............................................................. 6 Oral contraceptive brand change .................................................................. 6 Dentist rule changes...................................................................................... 7 Diabetes products update ............................................................................. 7 Azithromycin Suspension – new listing ......................................................... 7 Auranofin new listing and stock shortage ..................................................... 8 News In brief ................................................................................................. 8 Tender News .................................................................................................. 9 Looking Forward ........................................................................................... 9 Sole Subsidised Supply products cumulative to June 2012 ......................... 10 New Listings ................................................................................................ 21 Changes to Restrictions ............................................................................... 23 Changes to Subsidy and Manufacturer’s Price............................................. 30 Changes to Brand Name ............................................................................. 32 Changes to Sole Subsidised Supply ............................................................. 32 Delisted Items ............................................................................................. 33 Items to be Delisted .................................................................................... 35 Section H changes to Part II ........................................................................ 37 Section H changes to Part III........................................................................ 41 Index ........................................................................................................... 42

Summary of PHARMAC decisions

EFFECTIVE 1 JUNE 2012 New listings (page 21) • Sodium nitroprusside (Accu-Chek Ketur-Test) test strip, 50 strip OP – maximum of 50 strips per prescription – Not on a BSO • Azithromycin (Zithromax) grans for oral liq 200 mg per 5 ml, 15 ml – Subsidy by endorsement • Auranofin (Ridaura s29) tab 3 mg – Section 29 • Oxaliplatin (Oxaliplatin Actavis 50) inj 50 mg and (Oxaliplatin Actavis 100) inj 100 mg – PCT only – Specialist – Special Authority • Epirubicin (DBL Epirubicin Hydrochloride) inj 2 mg per ml, 25 ml, 2 mg per ml, 50 ml and 2 mg per ml, 100 ml – PCT only – Specialist Changes to restrictions (pages 23-26) • Ethinyloestradiol with levonorgestrel (Nordette 28 and Microgynon 30 ED) – removal of Special Authority for alternate subsidy • Prasugrel (Effient) tab 5 mg and 10 mg – Special Authority criteria amendment • Addition of stat dispensing to 34 chemicals Decreased subsidy (page 30) • Metoprolol succinate (Betaloc CR and Myloc CR) tab long acting 23.75 mg, 47.5 mg, 95 mg and 190 mg • Ethinyloestradiol with levonorgestrel (Levlen ED, Monofeme, Nordette 28 and Microgynon 30 ED) tab 30 µg with levonorgestrel 150 µg and 7 inert tab • Dexamethasone (Douglas) tab 1 mg and 4 mg • Mycophenolate mofetil (Myaccord) tab 500 mg and cap 250 mg

4 Pharmaceutical Schedule - Update News

Changes to Pharmaceutical Schedule subscriptions

From 1 July 2012 there will be a nominal charge to receive the hard copy publications of the Pharmaceutical Schedule. PHARMAC is introducing changes to the subscriptions for the Pharmaceutical Schedule publications. Subscribers will be able to receive electronic copies of the publications by email free of charge, where hard copies will attract a fee. You may prefer to receive an emailed link to a downloadable PDF copy, free of charge. This will be emailed to your nominated email address each time a new edition is published. You can activate this to receive either a free electronic version or paid hard copy by visiting the subscription website – www. schedule.co.nz – which will be live from late May 2012. Subscriptions will be managed via a secure website. There will be a two month lead in time for both the email and hard copy subscriptions, with the activation of these subscriptions from 12 July 2012, just in time for the August 2012 Update. Annual subscription fees for hard copies of the Pharmaceuticals Schedule and Updates will cost $55.00, and a combined subscription to Schedules/Updates and Section H will cost $65.00. These fees do not represent full cost recovery, but a contribution towards the cost of printing and postage.

We note that in addition to email and hard copy subscriptions the Pharmaceutical Schedule can also be freely accessed online, anytime, via the PHARMAC website. Functionality of the online Schedule continues to be improved and we welcome your suggestions for further improvement. Community pharmacies will receive one free hard copy subscription per licensed pharmacy site. This is a goodwill gesture by DHBs as part of the current Pharmacy Contracting discussions. Pharmacies may choose to purchase further hard copy subscriptions to the Pharmaceutical Schedule if they require more than one hard copy. Even if you sign up before the July cut off, your subscription will automatically start from July 2012 and run until June 2013. We will notify you to renew your hard copy subscription via email approximately six weeks before it expires.

Pharmaceutical Schedule - Update News

Medicines moving to Stat dispensing

From time to time, PHARMAC reviews pharmaceuticals for their suitability to move to all-at-once (or stat) dispensing. As a result of the latest review, from 1 June 2012, 34 pharmaceuticals will move from monthly dispensing to all-at-once or stat dispensing. This will reduce anomalies within therapeutic groups and list similar chemicals with the same dispensing period. Of the 39 chemicals that were consulted on, 34 chemicals will move to stat dispensing on 1 June 2012. Please see pages 23 – 26 for full details of which medicines are affected. For medicines where the first dispensing has occurred prior to 1 June 2012, the balance of the prescription will be dispensed stat, or all-at-once. It will not be dispensed in monthly lots. To be dispensed more frequently, prescribers will have to endorse the prescription Close Control. Patients who reside in residential facilities who are on one of these medicines, will need to have their repeats endorsed close control to facilitate the continuation of monthly dispensings. Further chemicals are to be reviewed and may be moved to stat dispensing at a later date following further clinical input and consultation.

Varenicline Special Authority

PHARMAC receives a number of calls relating to Special Authority applications for varenicline and would like to draw your attention to the current time limits associated with this Special Authority. The Special Authority for varenicline is valid for 5 months and the patient is entitled to a maximum of 12 weeks subsidised treatment within that 5 month period. Prescribers should ensure that their patients are aware that they have a limited time in which to complete their treatment. Applicants cannot apply for renewal of the Special Authority until 12 months after the date of the initial Special Authority approval. They can then apply using the renewal form. If a situation arises where the patient does not collect the full12 weeks of funded treatment, prescribers should call on PHARMAC 0800 66 00 50 for further advice.

Pharmaceutical Schedule - Update News

Change in subsidised brand for atorvastatin

A new brand of atorvastatin will be fully funded from 1 August 2012. The Zarator brand is supplied by Pfizer and will become the sole subsidised brand from 1 January 2013. Pfizer has advised that the ingredients and manufacturing processes for Zarator are exactly the same as Lipitor. The only changes will be the name, the packaging and the subsidy price. The Lipitor brand will be delisted on 1 January 2013.

Risperidone and Quetiapine – up coming subsidy changes for July 2012

From 1 July 2012, the subsidy for the Risperdal brand of risperidone tablets and oral liquid will be reduced to the level of subsidy for all the other currently funded brands of risperidone tablets and oral liquid. Also from 1 July 2012, the subsidy for the Quetapel brand of quetiapine tablets will be similarly reduced to the level of subsidy for the other currently funded brands of quetiapine tablets. To provide support for pharmacists in relation to these changes, PHARMAC is continuing to offer the Counselling Patients through Mental Health brand changes programme that was provided during 2011. For further details on this and to potentially organise one in your area, please contact Janet at janet.mackay@ pharmac.govt.nz.

Metoprolol – up coming sole supply

The Metoprolol-AFT CR brand of metoprolol succinate long-acting tablets 23.75 mg, 47.5 mg, 95 mg and 190 mg, supplied by AFT Pharmaceuticals, will be the sole subsidised brand from 1 September 2012. Last month saw a price and subsidy decrease for this brand. Betaloc CR and Myloc CR will have a subsidy decrease to the level of Metoprolol-AFT CR from 1 June 2012 and delisted from 1 September 2012.

Oral contraceptive brand change

From 1 June 2012, a subsidy decrease will apply to the following brands of oral contraceptive tablets containing 30 µg ethinyloestradiol with 150 µg levonorgestrel and 7 inert tablets: Levlen ED, Monofeme, Nordette 28 and Microgynon 30 ED. These brands will be delisted on 1 September 2012 to coincide with the commencement of sole supply of Ava 30 ED supplied by Arrow Pharmaceuticals.

Pharmaceutical Schedule - Update News

Dentist rule changes

It has been brought to our attention that “Dentist” has not been added to rule 3.1.4 in Section A of the Pharmaceutical Schedule. The change to this rule to include the change to dentist prescribing was notified in the December 2011 Update to coincide with the relevant changes to the Medicines Regulations 1984. The error will be corrected in the online Schedule from 1 June 2012 and in the next print version in August 2012.

Diabetes products update

We are continuing to work though the issues raised the in the responses to consultation on blood glucose testing meters and test strips and insulin pumps. In addition, we are continuing our dialogue with diabetes patient groups, clinicians and suppliers with the aim of reaching a decision that meets the needs of patients, clinicians and others working with people with diabetes. At this stage the earliest we would be in a position to announce a decision would be some time in July 2012. However, it may be later should the process take longer than anticipated. A proposal to fund Accu-chek Ketur Test ketone urinalysis strips has been approved and these will be listed on the Pharmaceutical Schedule from 1 June 2012.

Azithromycin Suspension – new listing

Azithromycin granules for oral liquid 200 mg per 5 ml will be funded from 1 June 2012 at a price and subsidy of $13.20 per 15 ml. The suspension will be subject to the wastage rule for all reconstituted antibiotics. The suspension will be restricted by endorsement to patients under one year of age who have pertussis or require prophylaxis for pertussis. The tablets are not funded for this indication and the suspension is not funded for any other indications.

Pharmaceutical Schedule - Update News

Auranofin new listing and stock shortage

From 1 June 2012, the Ridaura s29 brand of auranofin will be listed fully funded on the Pharmaceutical Schedule, however, PHARMAC has been advised that stock of the registered Ridaura product is limited and supplies of the new Ridaura s29 may be delayed. Ridaura s29 is not currently registered with Medsafe and must be supplied and prescribed in accordance with the provisions of Section 29 of the Medicines Act 1981. If neither of the Ridaura products are available patients should discuss alternative treatments with their doctors, for example Intramuscular sodium aurothiomalate (Myocrisin) injection which is fully funded or other anti-rheumatoid agents.

News In brief

• The delisting date for Atenolol Tablet USP 50 mg and 100 mg tablets has been extended to 25 November 2012 to allow pharmacists time to complete dispensing of the 1,000 tablet bottles. • The SC Profi-Fine , Fine Ject and DM Ject brands of insulin syringes will be delisted from 1 December 2012 due to supplier discontinuation. There are other fully funded brands available in all listed sizes. • The Arthrexin brand of indomethacin suppositories is being discontinued and will be delisted from 1 December 2012. PHARMAC has been unable to secure an alternative supply of indomethacin. • From 1 December 2012, the Cardinol brand of propranolol 40 mg tablets will be delisted. The Apo-Propranolol brand of 40 mg tablets is fully funded and is being supplied pursuant to section 29 of the Medicines Act 1981.

Tender News

Sole Subsidised Supply changes – effective 1 July 2012

Chemical Name Pramipexole hydrochloride Pramipexole hydrochloride Triamcinolone acetonide Triamcinolone acetonide Presentation; Pack size Tab 0.125 mg; 30 tab Tab 0.25 mg; 30 tab Inj 10 mg per ml, 1 ml; 5 inj Inj 40 mg per ml, 1 ml; 5 inj Sole Subsidised Supply brand (and supplier) Dr Reddy's Pramipexole (Dr Reddy's) Dr Reddy's Pramipexole (Dr Reddy's) Kenacort-A (Aspen) Kenacort-A40 (Aspen)

Looking Forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for implementation 1 July 2012 • Amino acid formula (Elecare and Elecare LCP) powder 400 g OP – subsidy and price decrease • Amino acid formula (Elecare, Elecare LCP, Neocate, Neocate LCP, Neocate Advance, Vivonex Pediatric) powder – amend Special Authority to remove “transition from old form” • Amino acid formula (Neocate, Neocate LCP, Neocate Advance, Neocate Gold) powder 400g OP – subsidy decrease • Buprenorphine with naloxone (Suboxone) tab sublingual 2 mg with naloxone 0.5 mg and 8 mg with naloxone 2 mg – new listing with Special Authority • Extensively hydrolysed formula (Pepti Junior Gold) powder – amend Special Authority to remove “transition from old form” • Felodipine (Plendil ER) tab 2.5 mg – removal of “No more than one tab per day” • Glucagon hydrochloride (Glucagen Hypokit) inj 1 mg syringe kit – subsidy increase • Insulin aspart (NovoMix 30 FlexPen) inj 100 iu per ml, 3 ml prefilled pen – new listing • Paediatric oral/enteral feed – amend age criteria for Special Authority • Standard supplements (Ensure) powder 900 g OP – subsidy and price increase Decision reminder 1 July 2012 • Ethinyloestradiol with levonorgestrel (Ava 20 ED) tab 20 µg with levonorgestrel 100 µg and 7 inert tab – new listing • Risperidone (Risperdal) tab 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg and oral liquid 1 mg per ml – subsidy decrease • Quetiapine (Quetapel) tab 25 mg, 100 mg, 200 mg and 300 mg – subsidy decrease

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Abacavir sulphate Acarbose Acetazolamide Aciclovir Allopurinol Amantadine hydrochloride Aminophylline Amitriptyline Amlodipine Amoxycillin

Presentation

Oral liq 20 mg per ml Tab 300 mg Tab 50 mg & 100 mg Tab 250 mg Tab dispersible 200 mg, 400 mg & 800 mg Tab 100 mg & 300 mg Cap 100 mg Inj 25 mg per ml, 10 ml Tab 25 mg & 50 mg Tab 2.5 mg Tab 5 mg & 10 mg Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg Grans for oral liq 250 mg per 5 ml Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Crm Tab 100 mg Tab 100 mg Tab dispersible 300 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Tab 50 mg Inj 50 mg Tab 500 mg Tab 10 mg Tab 2.5 mg & 5 mg Inj 600 mg Scalp app 0.1% Eye drops 0.5% Eye drops 0.25% Tab 50 mg Tab 5 mg

Brand Name Expiry Date*

Ziagen Ziagen Glucobay Diamox Lovir Apo-Allopurinol Symmetrel DBL Aminophylline Amitrip Apo-Amlodipine Apo-Amlodipine Ibiamox Alphamox Ospamox Curam Curam 2014 2012 2014 2013 2014 2014 2014 2014 2014 2014 2013 2012 2012

Amoxycillin clavulanate

Aqueous cream Ascorbic acid Aspirin Atenolol Atropine sulphate Azathioprine Azithromycin Baclofen Bendrofluazide Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Betaxolol hydrochloride Bicalutamide Bisacodyl

AFT Vitala-C Ethics Aspirin EC Ethics Aspirin Atenolol Tablet USP AstraZeneca Imuprine Imuran Arrow-Azithromycin Pacifen ArrowBendrofluazide Sandoz Beta Scalp Betoptic Betoptic S Bicalaccord Lax-Tab

2014 2013 2013 2012 2012 2013 2012 2012 2014 2014 2012 2014 2014 2013

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Calamine Calcitonin Calcitriol Calcium carbonate Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Ceftriaxone sodium Cefuroxime sodium Cephalexin monohydrate Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate Ciclopiroxolamine Cilazapril Cilazapril with hydrochlorothiazide Ciprofloxacin Citalopram hydrobromide Clarithromycin Clobetasol propionate

Presentation

Crm, aqueous, BP Lotn, BP Inj 100 iu per ml, 1 ml Cap 0.25 µg & 0.5 µg Tab 1.25 g (500 mg elemental) Tab eff 1.75 g (1 g elemental) Tab 15 mg Tab 12.5 mg, 25 mg & 50 mg Oral liq 5 mg per ml Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 500 mg Inj 1 g Inj 750 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Crm BP Oral liq 1 mg per ml Tab 10 mg Eye drops 0.5% Eye oint 1% Soln 4% Handrub 1% with ethanol 70% Nail soln 8% Tab 0.5 mg, 2.5 mg & 5 mg Tab 5 mg with hydrochlorothiazide 12.5 mg Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 500 mg Tab 250 mg Crm 0.05% Oint 0.05% Scalp app 0.05% TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Inj 150 µg per ml, 1 ml Tab 25 µg Tab 150 µg

Brand Name Expiry Date*

healthE API Miacalcic Airflow Arrow-Calcium Calsource DBL Leucovorin Calcium m-Captopril Capoten Ranbaxy-Cefaclor AFT Veracol Aspen Ceftriaxone Multichem Cefalexin Sandoz Cefalexin Sandoz PSM Cetirizine - AFT Zetop Chlorafast Chlorsig Orion healthE Batrafen Zapril Inhibace Plus Cipflox Arrow-Citalopram Apo-Clarithromycin Apo-Clarithromycin Dermol Dermol Dermol Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Catapres Dixarit Catapres 2012 2014 2012 2014 2014 2013 2013 2014 2013 2014 2012 2013 2014 2012 2014 2012 2012 2013 2013 2014 2014 2014 2012

Clonidine

2012

Clonidine hydrochloride

2012

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Clopidogrel Clotrimazole

Presentation

Tab 75 mg Crm 1% Vaginal crm 1% with applicator Vaginal crm 2% with applicator Soln BP Tab 500 µg Powder for soln for oral use 4.4 g Crm 10% Tab 50 mg Tab 50 mg Tab 50 mg & 100 mg Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs Nasal spray 10 µg per dose Eye oint 0.1% Eye drops 0.1% Inj 4 mg per ml, 1 ml & 2 ml

Brand Name Expiry Date*

Apo-Clopidogrel Clomazol Clomazol Clomazol Midwest Colgout Electral Itch-Soothe Nausicalm Cycloblastin Siterone Ginet 84 Desmopressin-PH&T Maxidex Maxidex Hospira Maxitrol Maxitrol 2013 2014 2013 2013 2013 2013 2012 2012 2013 2012 2014 2014 2014 2013 2013 2014

Coal tar Colchicine Compound electrolytes Crotamiton Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Cyproterone acetate with ethinyloestradiol Desmopressin Dexamethasone Dexamethasone sodium phosphate

Dexamethasone with neomycin Eye oint 0.1% with neomycin sulphate and polymyxin b sulphate 0.35% and polymyxin B sulphate 6,000 u per g Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml Dextrose Dextrose with electrolytes Inj 50%, 10 ml Soln with electrolytes

Biomed Pedialyte – Fruit Pedialyte – Bubblegum Pedialyte – Plain Voltaren Voltaren Ophtha Voltaren Diclofenac Sandoz DHC Continus Pytazen SR Laxofast 50 Laxofast 120 Laxsol Donepezil-Rex Apo-Doxazosin

2014 2013

Diclofenac sodium

Inj 25 mg per ml, 3 ml Eye drops 1 mg per ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab EC 25 mg & 50 mg Tab long-acting 60 mg Tab long-acting 150 mg Cap 50 mg Cap 120 mg Tab 50 mg with total sennosides 8 mg Tab 5 mg & 10 mg Tab 2 mg & 4 mg

2014

2012 2013 2014 2014 2013 2012 2014

Dihydrocodeine tartrate Dipyridamole Docusate sodium Docusate sodium with sennosides Donepezil hydrochloride Doxazosin mesylate

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Doxycycline hydrochloride Emulsifying ointment Enalapril Enoxaparin sodium (low molecular weight heparin) Entacapone Ergometrine maleate Erythromycin ethyl succinate Escitalopram Ethinyloestradiol Etidronate disodium Exemestane Felodipine Fentanyl

Presentation

Tab 100 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Inj 500 µg per ml, 1 ml Tab 400 mg Tab 10 mg & 20 mg Tab 10 µg Tab 200 mg Tab 25 mg Tab long-acting 5 mg Tab long-acting 10 mg Transdermal patch 12.5 µg per hour, 25 µg per hour, 50 µg per hour, 75 µg per hour, 100 µg per hour Inj 50 µg per ml, 2 ml & 10 ml Oral liq 30 mg per 1 ml (6 mg elemental per 1 ml) Tab 5 mg Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 50 mg, 150 mg & 200 mg Eye drops 0.1% Cap 20 mg Tab dispersible 20 mg, scored Tab 250 mg Metered aqueous nasal spray, 50 µg per dose Inj 10 mg per ml, 2 ml Tab 40 mg Crm 2% Oint 2% Cap 100 mg, 300 mg & 400 mg Tab 600 mg Inj 40 mg per ml, 2 ml

Brand Name Expiry Date*

Doxine AFT Arrow-Enalapril Clexane Comtan DBL Ergometrine E-Mycin Loxalate NZ Medical and Scientific Arrow-Etidronate Aromasin Felo 5 ER Felo 10 ER Mylan Fentanyl Patch Boucher and Muir Ferodan Rex Medical Flucloxin AFT AFT AFT Ozole FML Fluox Fluox Flutamin Flixonase Hayfever & Allergy Frusemide-Claris Diurin 40 Foban Foban Nupentin Lipazil Pfizer 2014 2014 2012 2012 2012 2014 2012 2013 2012 2012 2014 2012 2013

Fentanyl citrate Ferrous sulphate Finasteride Flucloxacillin sodium

2012 2013 2014 2014 2012

Fluconazole Fluorometholone Fluoxetine hydrochloride Flutamide Fluticasone propionate Furosemide Fusidic acid Gabapentin Gemfibrozil Gentamicin sulphate

2014 2012 2013 2013 31/1/13 2013 2012 2013 31/7/12 2013 2012

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Gliclazide Glycerol Glyceryl trinitrate

Presentation

Tab 80 mg Liquid Aerosol spray 400 µg per dose TDDS 5 mg & 10 mg Tab 600 µg Inj 5 mg per ml, 1 ml Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Crm 1% Powder Inj 50 mg per ml, 1 ml Tab 5 mg & 20 mg Rectal foam 10%, CFC-free (14 applications) Crm 1% with miconazole nitrate 2% Lotn 1% with wool fat hydrous 3% and mineral oil Inj 1 mg per ml, 1 ml Tab 200 mg Inj 20 mg, 1 ml Tab 10 mg Tab 200 mg Tab long-acting 800 mg Oral liq 100 mg per 5 ml Crm 5% Tab 2.5 mg Aqueous nasal spray, 0.03%, 15 ml OP Nebuliser soln, 250 µg per ml, 1 ml & 2 ml Inj 50 mg per ml, 2 ml Tab 20 mg Tab long-acting 40 mg Cap 10 mg & 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Oral liq 10 mg per ml Tab 150 mg

Brand Name Expiry Date*

Apo-Gliclazide healthE Glytrin Nitroderm TTS Lycinate Serenace Serenace Serenace Pharmacy Health ABM Solu-Cortef Douglas Colifoam Micreme H DP Lotn HC ABM Hydroxocobalamin Plaquenil Buscopan Gastrosoothe Arrowcare Brufen SR Fenpaed Aldara Dapa-Tabs Univent Univent Ferrum H Ismo 20 Corangin Oratane Itrazole Sebizole Laevolac 3TC 3TC 2014 2014 2012 2013 2014 2013 2013 2014 2013 2014

Haloperidol

2013

Hydrocortisone

2014 2013 2012 2012 2013 2014 2012 2012 2014 2014 2013 2014 2013 2013

Hydrocortisone acetate Hydrocortisone with miconazole Hydrocortisone with wool fat and mineral oil Hydroxocobalamin Hydroxychloroquine sulphate Hyoscine N-butylbromide Ibuprofen

Imiquimod Indapamide Ipratropium bromide

Iron polymaltose Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Lamivudine

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Latanoprost Letrozole Levonorgestrel Lignocaine hydrochloride Lignocaine with prilocaine

Presentation

Eye drops 50 µg per ml Tab 2.5 mg Subdermal implant (2 x 75 mg rods) Viscous soln 2% Inj 1%, 5 ml & 20 ml Crm 2.5% with prilocaine 2.5% (5 g tubes) Crm 2.5% with prilocaine 2.5%; 30 g OP Tab 5 mg, 10 mg & 20 mg Cap 250 mg Eye drops 0.1% Cap 2 mg Oral liq 1 mg per ml Tab 10 mg Tab 1 mg & 2.5 mg Tab 12.5 mg, 25 mg, 50 mg & 100 mg Tab 50 mg with hydrochlorothiazide 12.5 mg Liq 0.5% Shampoo 1% Size 2 Tab 100 mg Tab 135 mg Tab 160 mg Tab 50 mg Suppos 500 mg Enema 1 g per 100 ml Tab immediate-release 500 mg & 850 mg Tab 5 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 25 mg per ml, 2 ml & 20 ml Tab 2.5 mg & 10 mg Tab 4 mg & 100 mg

Brand Name Expiry Date*

Hysite Letara Jadelle Xylocaine Viscous Xylocaine EMLA EMLA Arrow-Lisinopril Douglas Lomide Diamide Relief Lorapaed Loraclear Hayfever Relief Ativan Lostaar Arrow-Losartan & Hydroclorothiazide A-Lices A-Lices EZ-fit Paediatric Mask De-Worm Colofac Apo-Megestrol Purinethol Asacol Pentasa Apotex Methatabs Biodone Biodone Forte Biodone Extra Forte Hospira Methoblastin Medrol 2012 2014 2014 2013 2013 2012 2012 31/12/13 2014 2013 2013

Lisinopril Lithium carbonate Lodoxamide trometamol Loperamide hydrochloride Loratadine

Lorazepam Losartan Losartan with hydrochlorothiazide Malathion Mask for spacer device Mebendazole Mebeverine hydrochloride Megestrol acetate Mercaptopurine Mesalazine Metformin hydrochloride Methadone hydrochloride

2013 2014 2014 2013 2015 2014 2014 2012 2013 2014 2012 2012 2013 2012

Methotrexate Methylprednisolone

2013 2012 2012

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Methylprednisolone sodium succinate

Presentation

Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Inj 5 mg per ml, 2 ml Tab 10 mg Crm 2% Tab 150 mg & 300 mg Crm 0.1% Oint 0.1% Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 5 mg per ml, 1 ml Inj 10 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab long-acting 10 mg, 30 mg, 60 mg & 100 mg Cap long-acting 10 mg, 30 mg, 60 mg & 100 mg Tab immediate release 10 mg & 20 mg

Brand Name Expiry Date*

Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Metamide Multichem Apo-Moclobemide m-Mometasone m-Mometasone RA-Morph RA-Morph RA-Morph RA-Morph DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate Arrow-Morphine LA m-Elson Sevredol Hospira Konsyl-D Naphcon Forte Noflam 250 Noflam 500 Naltraccord AstraZeneca Viramune Suspension Viramune Habitrol Habitrol Habitrol Apo-Nicotinic Acid Arrow-Norfloxacin 2014 2014 2012 2013 2013 2014 2012 2013 2014 2012 2012

Metoclopramide hydrochloride Miconazole nitrate Moclobemide Mometasone furoate Morphine hydrochloride

2014 2014 2012 2012 2012

Morphine sulphate

2014

2013

Morphine tartrate Mucilaginous laxatives Naphazoline hydrochloride Naproxen Naltrexone hydrochloride Neostigmine Nevirapine

Inj 80 mg per ml, 1.5 ml & 5 ml Dry Eye drops 0.1% Tab 250 mg Tab 500 mg Tab 50 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 200 mg

Nicotine

Gum 2 mg & 4 mg (classic, fruit, mint) Lozenge 1 mg & 2 mg Patch 7 mg, 14 mg & 21 mg Tab 50 mg & 500 mg Tab 400 mg

2014

Nicotinic acid Norfloxacin

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Norethisterone Nystatin

Presentation

Tab 5 mg Tab 350 µg Oral liq 100,000 u per ml Cap 500,000 u Tab 500,000 u Cap 10 mg, 20 mg & 40 mg Powder Inj 40 mg Tab disp 4 mg & 8 mg Tab 4 mg & 8 mg

Brand Name Expiry Date*

Primolut N Noriday 28 Nilstat Nilstat Nilstat Omezol Relief Midwest Dr Reddy’s Omeprazole Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron Ox-Pam Syntocinon Syntocinon Syntometrine Pantocid IV Dr Reddy’s Pantoprazole Parafast Ethics Paracetamol Paracare Double Strength Paracetamol + Codeine (Relieve) Lacri-Lube Loxamine Breath-Alert Pegasys Pegasys Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Permax Lyderm A-Scabies 2014 2012 2014 2013 2014

Omeprazole

Ondansetron

2013

Oxazepam Oxytocin

Tab 10 mg & 15 mg Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 40 mg Tab 20 mg & 40 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab paracetamol 500 mg with codeine phosphate 8 mg Eye oint with soft white paraffin Tab 20 mg Low range & normal range Inj 135 µg prefilled syringe Inj 180 µg prefilled syringe Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Tab 0.25 mg & 1 mg Crm 5% Lotn 5%

2014 2012

Pantoprazole

2014 2013 2014

Paracetamol

Paracetamol with codeine Paraffin liquid with soft white paraffin Paroxetine hydrochloride Peak flow meter Pegylated interferon alpha-2A

2014 2013 2013 2015 31/12/12

Pergolide Permethrin

2014 2014

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Pethidine hydrochloride

Presentation

Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 2 ml

Brand Name Expiry Date*

DBL Pethidine Hydrochloride DBL Pethidine Hydrochloride Cilicaine VK AFT AFT Apo-Pindolol Pizaccord Sandomigran Coloxyl Span-K Cholvastin Redipred Innovacon hCG One Step Pregnancy Test Cilicaine Promethazine Winthrop Elixir Mestinon PyridoxADE Apo-Pyridoxine Q 300 Peptisoothe Arrow-Ranitidine Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Duolin 2012 2012 2012 2014 2012 2014 2012 2012 2014 2012 2014 2014 2012 2014 2013 2013 2012 2012 2012 2014

Phenoxymethylpenicillin (Pencillin V)

Cap potassium salt 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Tab 5 mg, 10 mg & 15 mg Tab 15 mg, 30 mg & 45 mg Tab 500 µg Oral drops 10% Tab long-acting 600 mg Tab 20 mg & 40 mg Oral liq 5 mg per ml Cassette Inj 1.5 mega u Oral liq 5 mg per 5 ml Tab 60 mg Tab 25 mg Tab 50 mg Tab 300 mg Oral liq 150 mg per 10 ml Tab 150 mg & 300 mg Cap 150 mg Tab 0.25 mg, 1 mg, 2 mg & 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Nebuliser soln, 2.5 mg with ipratopium bromide 0.5 mg per vial, 2.5 ml Tab 5 mg Tab 50 mg & 100 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg

2013

Pindolol Pioglitazone Pizotifen Poloxamer Potassium chloride Pravastatin Prednisolone sodium phosphate Pregnancy tests – hCG urine Procaine penicillin Promethazine hydrochloride Pyridostigmine bromide Pyridoxine hydrochloride Quinine sulphate Ranitidine hydrochloride Rifabutin Ropinirole hydrochloride Roxithromycin Salbutamol Salbutamol with ipratropium bromide Selegiline hydrochloride Sertraline Simvastatin

Apo-Selegiline Arrow-Sertraline Arrow-Simva 10mg Arrow-Simva 20mg Arrow-Simva 40mg Arrow-Simva 80mg

2012 2013 2014

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Sodium chloride Sodium citrate with sodium lauryl sulphoacetate Sodium citro-tartrate Sodium cromoglycate Somatropin Sotalol Spacer device

Presentation

Inj 23.4%, 20 ml Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml Grans effervescent 4 g sachets Eye drops 2% Nasal spray, 4% Inj cartridge 16 iu (5.3 mg) Inj cartridge 36 iu (12 mg) Tab 80 mg & 160 mg 800 ml 230 ml (single patient) Tab 25 mg & 100 mg Inj 12 mg per ml, 0.5 ml Tab 50 mg & 100 mg Tab 20 mg Cap 400 µg Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium, 500 ml & 1,000 ml Tab 10 mg Cap 5 mg, 20 mg, 100 mg & 250 mg Tab 1 mg, 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Cap 40 mg Inj 250 µg Inj 1 mg per ml, 1 ml Eye drops 0.25% & 0.5% Tab 10 mg Eye drops 0.3% Eye oint 0.3% Inj 40 mg per ml, 2 ml Tab 100 mg Cap 50 mg Crm 0.02% Oint 0.02% 0.1% in Dental Paste USP Tab 500 mg Eye drops 0.5% & 1%

Brand Name Expiry Date*

Biomed Micolette Ural Rexacrom Rex Genotropin Genotropin Mylan Volumatic Space Chamber Plus Spirotone Arrow-Sumatriptan Arrow-Sumatriptan Genox Tamsulosin-Rex Pinetarsol 2013 2013 2013 2013 2012 31/12/12 2012 2015

Spironolactone Sumatriptan Tamoxifen citrate Tamsulosin hydrochloride Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Temozolomide Terazosin hydrochloride Terbinafine Testosterone cypionate Testosterone undecanoate Tetracosactrin Timolol maleate Tobramycin

2013 2013 2014 2013 2014

Normison Temaccord Arrow Dr Reddy’s Terbinafine Depo-Testosterone Arrow-Testosterone Synacthen Synacthen Depot Arrow-Timolol Apo-Timol Tobrex Tobrex DBL Tobramycin Tasmar Arrow-Tramadol Aristocort Aristocort Oracort Cyklokapron Mydriacyl

2014 2013 2013 2014 2014 2012 2014 2014 2012 2014

Tolcapone Tramadol hydrochloride Triamcinolone acetonide

2014 2014 2014

Tranexamic acid Tropicamide

2013 2014

Sole Subsidised Supply Products – cumulative to June 2012

Generic Name

Tropisetron Tyloxapol Vancomycin hydrochloride Verapamil hydrochloride Vitamin B complex Vitamins Zidovudine [AZT] Zinc sulphate Zopiclone June changes in bold

Presentation

Cap 5 mg Eye drops 0.25% Inj 500 mg Tab 40 mg & 80 mg Tab, strong, BPC Tab (BPC cap strength) Cap 100 mg Oral liq 10 mg per ml Caps 137.4 mg (50 mg elemental) Tab 7.5 mg

Brand Name Expiry Date*

Navoban Enuclene Mylan Isoptin B-PlexADE MultiADE Retrovir Retrovir Zincaps Apo-Zopiclone 2012 2014 2014 2014 2013 2013 2013 2014 2014

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 June 2012

31 SODIUM NITROPRUSSIDE – Maximum of 50 strip per prescription Test strip – Not on a BSO .......................................................... 6.00 50 strip OP ✔ Accu-Chek KeturTest

AZITHROMYCIN Grans for oral liq 200 mg per 5 ml - Subsidy by endorsement ................................................................... 13.20 15 ml ✔ Zithromax a) Maximum of 5 days per prescription where the patient is less than one year old; and b) Patient has pertussis and this has been notified to the Medical Officer of Health; or c) Patient has had direct contact with a notified case of pertussis and requires prophylaxis; d) And the prescription is endorsed accordingly (note treatment and prophylaxis of pertussis are unapproved indications) AURANOFIN Tab 3 mg ............................................................................... 68.99 OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 Inj 50 mg ................................................................................ 15.32 Inj 100 mg .............................................................................. 25.01 60 1 1 ✔ Ridaura S29 S29 ✔ Oxaliplatin Actavis 50 ✔ Oxaliplatin Actavis 100 ✔ DBL Epirubicin Hydrochloride ✔ DBL Epirubicin Hydrochloride ✔ DBL Epirubicin Hydrochloride

98 140

147

EPIRUBICIN – PCT only – Specialist Inj 2 mg per ml, 25 ml ............................................................. 39.38 Inj 2 mg per ml, 50 ml ............................................................ 58.20 Inj 2 mg per ml, 100 ml .......................................................... 94.50

1 1 1

Effective 1 May 2012

51 BISOPROLOL FUMARATE Tab 2.5 mg ............................................................................... 3.88 Tab 5 mg .................................................................................. 4.74 Tab 10 mg ................................................................................ 9.18 PROPYLTHIOURACIL – Special Authority see SA1199 – Retail Pharmacy Tab 50 mg .............................................................................. 35.00 30 30 30 100 ✔ Bosvate ✔ Bosvate ✔ Bosvate ✔ PTU S29

➽ SA1199 Special Authority for Subsidy Initial application only from any relevant practitioner. Approvals valid for 2 years for applications meeting the following criteria: Both: 1 The patient has hyperthyroidism; and 2 The patient is intolerant of carbimazole or carbimazole is contraindicated. Renewal from any relevant practitioner. Approvals valid for 2 years where the treatment remains appropriate and the patient is benefitting from the treatment. 170 BRIMONIDINE TARTRATE ❋ Eye Drops 0.2%......................................................................... 6.45 5 ml OP ✔ Arrow-Brimonidine

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings – effective 13 April 2012

140 CARBOPLATIN – PCT only – Specialist Inj 10 mg per ml, 45 ml ........................................................... 50.00 1 ✔ DBL Carboplatin

Effective 1 April 2012

147 164 DOXORUBICIN – PCT only – Specialist Inj 50 mg ............................................................................... 40.00 SALBUTAMOL ‡ Oral liq 2 mg per 5 ml ............................................................. 1.99 1 150 ml ✔ DBL Doxorubicin ✔ Ventolin

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 June 2012

26 31 ALUMINIUM HYDROXIDE (addition of stat dispensing) ❋ Tab 600 mg .......................................................................... 12.56 100 ✔ Alu-Tab

❋ Tab 15 mg .............................................................................. 2.61 ❋ Tab 30 mg .............................................................................. 5.23 ❋ Tab 45 mg .............................................................................. 7.80 ❋ Cap 0.25 µg ......................................................................... 26.32 ❋ Cap 1 µg .............................................................................. 87.98 ❋ Oral drops 2 µg per ml .......................................................... 60.68 ❋ Powder ................................................................................. 72.00 ❋ Soln 1000 u with Vitamin D 400 u and ascorbic acid 30 mg

SODIUM FLUORIDE (addition of stat dispensing) VITAMIN A WITH VITAMINS D AND C (addition of stat dispensing) per 10 drops ......................................................................... 4.50 ALFACALCIDOL (addition of stat dispensing)

PIOGLITAZONE – Special Authority see SA0959 – Retail pharmacy (addition of stat dispensing) 28 ✔ Pizaccord 28 ✔ Pizaccord 28 ✔ Pizaccord 100 100 20 ml OP ✔ One-Alpha ✔ One-Alpha ✔ One-Alpha

37 37

MULTIVITAMINS – Special Authority see SA1036 – Retail pharmacy (addition of stat dispensing) 200 g OP ✔ Paediatric Seravit

10 ml OP 100 90 100

✔ Vitadol C ✔ PSM

❋ Tab 1.1 mg (0.5 mg elemental) ............................................... 5.00 ❋ Tab 256 µg (150 µg elemental iodine) ..................................... 7.55 ❋ Tab 200 mg (65 mg elemental) ............................................... 4.35 ❋ Tab 310 mg (100 mg elemental) with folic acid

IRON POLYMALTOSE (addition of stat dispensing) FERROUS FUMARATE WITH FOLIC ACID (addition of stat dispensing) 350 µg .................................................................................. 4.75 FERROUS FUMARATE (addition of stat dispensing) POTASSIUM IODATE (addition of stat dispensing)

38 38 38

✔ NeuroKare ✔ Ferro-tab

60 5 10

✔ Ferro-F-Tabs ✔ Ferrum H ✔ Mayne

❋ Inj 50 mg per ml, 2 ml ........................................................... 19.90 ❋ Inj 49.3%, 5 ml

MAGNESIUM SULPHATE (addition of stat dispensing) ..................................................................... 26.60 CLOPIDOGREL (addition of stat dispensing) ❋ Tab 75 mg – For clopidogrel oral liquid formulation refer, page 175 ............................................................................ 16.25

39 41

✔ Apo-Clopidogrel

PRASUGREL – Special Authority see SA1201 1194 – Retail pharmacy Tab 5 mg ............................................................................. 108.00 28 ✔ Effient Tab 10 mg ........................................................................... 120.00 28 ✔ Effient ➽ SA1201 1194 Special Authority for Subsidy Initial application - (coronary angioplasty and bare metal stent) from any relevant practitioner. Approvals valid for 6 months where the patient has undergone coronary angioplasty or had a bare metal cardiac stent inserted in the previous 4 weeks and is clopidogrel-allergic*. Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. continued... ❋ Three months or six months, as applicable, dispensed all-at-once

▲

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 June 2012 (continued)

continued... Initial application - (drug eluting stent) from any relevant practitioner. Approvals valid for 12 months where the patient has had a drug-eluting cardiac stent inserted in the previous 4 weeks and is clopidogrel-allergic*. Initial application – (stent thrombosis) from any relevant practitioner. Approvals valid without further renewal unless notified where the patient has experienced cardiac stent thrombosis whilst on clopidogrel. Renewal - (coronary angioplasty and bare metal stent) from any relevant practitioner. Approvals valid for 6 months where the patient has undergone coronary angioplasty or had a bare metal cardiac stent inserted in the previous 4 weeks and is clopidogrel-allergic*. Renewal - (drug eluting stent) from any relevant practitioner. Approvals valid for 12 months where the patient has had a drug-eluting cardiac stent inserted in the previous 4 weeks and is clopidogrel-allergic*. Note: *Clopidogrel allergy is defined as a history of anaphylaxis, urticaria, generalised rash or asthma (in nonasthmatic patients) developing soon after clopidogrel is started and is considered unlikely to be caused by any other treatment. 45 GEMFIBROZIL (addition of stat dispensing)

❋ Tab 600 mg .......................................................................... 14.00 ❋ Tab 20 mg .............................................................................. 5.44 ❋ Tab 40 mg .............................................................................. 9.28 ❋ Tab 6.25 mg ......................................................................... 21.00 ❋ Tab 12.5 mg ......................................................................... 27.00 ❋ Tab 25 mg – For carvedilol oral liquid formulation refer,

page 175 ............................................................................ 33.75 ISRADIPINE (addition of stat dispensing) CARVEDILOL (addition of stat dispensing) PRAVASTATIN – See prescribing guideline (addition of stat dispensing)

60 30 30 30 30 30 30 30 500 g

✔ Lipazil ✔ Cholvastin ✔ Cholvastin ✔ Dilatrend ✔ Dilatrend ✔ Dilatrend ✔ Dynacirc-SRO ✔ Dynacirc-SRO ✔ Multichem PSM

❋ Cap long-acting 2.5 mg ........................................................... 7.50 ❋ Cap long-acting 5 mg .............................................................. 7.85 ❋ Oint BP

ZINC AND CASTOR OIL (addition of stat dispensing) ................................................................................... 3.83 (5.11)

ETHINYLOESTRADIOL WITH LEVONORGESTREL ❋ Tab 30 µg with levonorgestrel 150 µg and 7 inert tab................. 2.45 (6.62)

✔ Ava 30 ED Levlen ED Monofeme (14.49) Nordette 28 (16.50) Microgynon 30 ED a) Higher subsidy of up to $15.00 per 84 tab with Special Authority see SA0500 on the preceding page b) Up to 84 tab available on a PSO

❋ Tab 5 mg ................................................................................ 5.10 ❋ Cap 400 µg

FINASTERIDE – Special Authority see SA0928 – Retail pharmacy (addition of stat dispensing) 30 ✔ Rex Medical TAMSULOSIN HYDROCHLORIDE – Special Authority see SA1032 – Retail pharmacy (addition of stat dispensing) ............................................................................ 5.98 30 ✔ Tamsulosin-Rex

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 June 2012 (continued)

❋ Tab 250 mg – For terbinafine oral liquid formulation refer,

page 175 .............................................................................. 1.78 14 ✔ Dr Reddy’s Terbinafine

TERBINAFINE (addition of stat dispensing)

❋ Tab 7.5 mg ........................................................................... 11.50 ❋ Tab 70 mg ............................................................................ 22.90

MELOXICAM – Special Authority see SA1034 – Retail pharmacy (addition of stat dispensing) 30 ✔ Arrow-Meloxicam ALENDRONATE SODIUM – Special Authority see SA1039 – Retail pharmacy (addition of stat dispensing) 4 ✔ Fosamax

109 109

109

ALENDRONATE SODIUM WITH CHOLECALCIFEROL – Special Authority see SA1039 – Retail pharmacy (addition of stat dispensing) ❋ Tab 70 mg with cholecalciferol 5,600 iu ................................ 22.90 4 ✔ Fosamax Plus

❋ Tab 40 mg .......................................................................... 133.00

ALENDRONATE SODIUM – Special Authority see SA0949 – Retail pharmacy (addition of stat dispensing) 30 ✔ Fosamax RALOXIFENE HYDROCHLORIDE – Special Authority see SA1138 – Retail pharmacy (addition of stat dispensing) 28 ✔ Evista

110 119

❋ Tab 60 mg ............................................................................ 53.76

119

MOCLOBEMIDE (addition of stat dispensing) Note: There is a significant cost differential between moclobemide and fluoxetine (moclobemide being about three times more expensive). For depressive syndromes it is therefore more cost-effective to start treatment with fluoxetine first before considering prescribing moclobemide. ❋ Tab 150 mg .......................................................................... 69.23 500 ✔ Apo-Moclobemide ❋ Tab 300 mg .......................................................................... 31.33 100 ✔ Apo-Moclobemide

❋ Tab 15 mg ............................................................................ 95.00 ❋ Tab 10 mg ............................................................................ 22.94 ❋ Tab 10 mg .............................................................................. 2.65 ❋ Tab 20 mg .............................................................................. 4.20 ❋ Tab 20 mg .............................................................................. 2.38 ❋ Tab 50 mg .............................................................................. 5.40 ❋ Tab 100 mg ............................................................................ 9.60

SERTRALINE (addition of stat dispensing) PAROXETINE HYDROCHLORIDE (addition of stat dispensing) ESCITALOPRAM (addition of stat dispensing) TRANYLCYPROMINE SULPHATE (addition of stat dispensing)

PHENELZINE SULPHATE (addition of stat dispensing)

100 50 28 28 30 90 90

✔ Nardil ✔ Parnate ✔ Loxalate ✔ Loxalate ✔ Loxamine ✔ Arrow-Sertraline ✔ Arrow-Sertraline

119 120

120 120

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 June 2012 (continued)

126

❋ Tab 4 mg ................................................................................ 5.10 ❋ Tab disp 4 mg ......................................................................... 1.70 ❋ Tab 8 mg ................................................................................ 1.70 ❋ Tab disp 8 mg ......................................................................... 2.00

ANASTROZOLE (addition of stat dispensing)

ONDANSETRON (addition of stat dispensing)

30 10 10 10

✔ Dr Reddy’s Ondansetron ✔ Dr Reddy’s Ondansetron ✔ Dr Reddy’s Ondansetron ✔ Dr Reddy’s Ondansetron ✔ Aremed ✔ Arimidex ✔ DP-Anastrozole ✔ Aromasin ✔ Letara

155

❋ Tab 1 mg .............................................................................. 26.55

30 30 30

155

❋

EXEMESTANE (addition of stat dispensing) Tab 25 mg .......................................................................... 22.57 LETROZOLE (addition of stat dispensing)

155

❋ Tab 2.5 mg ........................................................................... 26.55

Effective 1 May 2012

44 SODIUM CHLORIDE Not funded for use as a nasal drop. Only funded for nebuliser use when in conjunction with an antibiotic intended for nebuliser use. Inj 23.4%, 20 ml - For sodium chloride oral liquid formulation refer, page 178 ................................................ 31.25 5 ✔ Biomed CICLOPIROXOLAMINE CICLOPIROX OLAMINE a) Only on a prescription b) Not in combination Nail soln 8% .......................................................................... 19.85 Soln 1% .................................................................................... 4.36 (11.54)

3 g OP 20 ml OP

✔ Batrafen Batrafen

143

GEMCITABINE HYDROCHLORIDE – PCT only – Specialist – Special Authority see SA1087 Inj 1 g ..................................................................................... 62.50 1 ✔ Gemcitabine Actavis Inj 200 mg .............................................................................. 12.50 1 1000 S29 ✔ Gemcitabine Actavis 200 S29

152

SUNITINIB – Special Authority see SA1200 1162 – Retail pharmacy Cap 12.5 mg ..................................................................... 2,315.38 Cap 25 mg ......................................................................... 4,630.77 Cap 50 mg ......................................................................... 9,261.54

28 28 28

✔ Sutent ✔ Sutent ✔ Sutent

➽ SA1200 1162 Special Authority for Subsidy Initial application only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 3 months for applications meeting the following criteria: All of the following: 1 The patient has metastatic renal cell carcinoma; and 2 Either Any of the following: 2.1 The patient is sunitinib treatment naive; or continued... Patients pay a manufacturer’s surcharge when S29 Unapproved medicine supplied under Section 29 the Manufacturer’s Price is greater than the Subsidy ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2012 (continued)

continued... 2.2 The patient received sunitinib prior to 1 November 2010 and disease has not progressed; and The patient has only received prior cytokine treatment; or 2.3 The patient has only received prior treatment with an investigational agent within the confines of a bona fide clinical trial which has Ethics Committee approval; or 2.4 Both 2.4.1 The patient has discontinued pazopanib within 3 months of starting treatment due to intolerance; and 2.4.2 The cancer did not progress whilst on pazopanib; and The patient has good performance status (WHO/ECOG grade 0-2); and The disease is of predominant clear cell histology; and The patient has intermediate or poor prognosis defined as : Any of the following: 5.1 Lactate dehydrogenase level > 1.5 times upper limit of normal; or 5.2 Haemoglobin level < lower limit of normal; or 5.3 Corrected serum calcium level > 10 mg/dL (2.5 mmol/L) ; or 5.4 Interval of < 1 year from original diagnosis to the start of systemic therapy; or 5.5 Karnofsky performance score of ≤ 70; or 5.6 ≥ 2 sites of organ metastasis; and Sunitinib to be used for a maximum of 2 cycles.

3 4 5

Renewal only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 3 months for applications meeting the following criteria: Both: 1 No evidence of disease progression; and 2 The treatment remains appropriate and the patient is benefiting from treatment. Notes: Sunitinib treatment should be stopped if disease progresses. Poor prognosis patients are defined as having at least 3 of criteria 5.1-5.6. Intermediate prognosis patients are defined as having 1 or 2 of criteria 5.1-5.6 156 Immune Modulators Protein-Tyrosine Kinase Inhibitors LAPATINIB DITOSYLATE – Special Authority see SA1191 – Retail pharmacy Tab 250 mg ...................................................................... 1,899.00 170 70 ✔ Tykerb

Glaucoma Preparations - Carbonic Anhydrase Inhibitors Prescribing Guidelines Trusopt, Cosopt and Azopt are subsidised for use as either monotherapy or as an adjunctive agent for the treatment of glaucoma. Trusopt, Cosopt and Azopt should not be prescribed for a person in whom less expensive first line agents for the treatment of glaucoma are not contraindicated unless: 1) that person has previously trialled all other such subsidised agents (except brimonidine tartrate); and 2) those trials have indicated that that person does not respond adequately to treatment with those other agents. ACETAZOLAMIDE ❋ Tab 250 mg – For acetazolamide oral liquid formulation refer, page 175 ............................................................................ 17.03 BRINZOLAMIDE (change to stat dispensing) s ❋ Eye Drops 1% ..................................................................... 9.77 DORZOLAMIDE HYDROCHLORIDE ❋ Eye drops 2% ........................................................................... 9.77 (13.95)

100 5 ml OP 5 ml OP

✔ Diamox ✔ Azopt

Trusopt

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2012 (continued)

170 DORZOLAMIDE HYDROCHLORIDE WITH TIMOLOL MALEATE ❋ Eye drops 2% with timolol maleate 0.5% ................................. 15.50 5 ml OP ✔ Cosopt

Glaucoma Preparations - Prostaglandin Analogues Prescribing Guideline Bimatoprost, lantanoprost and travoprost are subsidised for use in the treatment of glaucoma as either monotherapy or as an adjunctive agent for patients in whom prostaglandin analogue monotherapy has been ineffective in controlling intraocular pressure. Bimatoprost, lantanoprost and travoprost should not be prescribed for a person in whom less expensive first line agents for the treatment of glaucoma are not contraindicated unless: 1) That person has previously trialled all other such subsidised agents (beta-blockers, pilocarpine, carbonic anhydrase inhibitors); and 2) Those trials have indicated that that person does not respond adequately to treatment with those other agents. BIMATOPROST – Retail pharmacy-Specialist (change to stat dispensing) See prescribing guideline above s ❋ Eye drops 0.03% ............................................................... 18.50 LATANOPROST – Retail pharmacy-Specialist (change to stat dispensing) See prescribing guideline above s ❋ Eye drops 50 µg per ml, 2.5 ml ........................................... 9.75 TRAVOPROST – Retail pharmacy-Specialist (change to stat dispensing) See prescribing guideline above s ❋ Eye drops 0.004% ............................................................ 19.50 Glaucoma Preparations - Other BRIMONIDINE TARTRATE – See prescribing guideline below ❋ Eye Drops 0.2% ........................................................................ 6.45 7.93

170

3 ml OP

✔ Lumigan

2.5 ml OP ✔ Hysite

170

2.5 ml OP ✔ Travatan

5 ml OP

✔ Arrow-Brimonidine ✔ AFT

Prescribing Guidelines Brimonidine tartrate is subsidised for use as either monotherapy or as an adjunctive agent for the treatment of glaucoma. Brimonidine tartrate should not be prescribed for a person in whom less expensive first line agents for the treatment of glaucoma are not contraindicated unless: • that person has previously trialled all other such subsidised agents (except dorzolamide hydrochloride); and • those trials have indicated that that person does not respond adequately to or does not tolerate treatment with those other agents. 171 BRIMONIDINE TARTRATE WITH TIMOLOL MALEATE – See prescribing guideline below (change to stat dispensing) s ❋ Eye drops 0.2% with timolol maleate 0.5% ......................... 18.50 5 ml OP ✔ Combigan Prescribing Guidelines Combigan is subsidised for use as either monotherapy or as an adjunctive agent for the treatment of glaucoma. Combigan should only be prescribed when: 1) less expensive first line agents for the treatment of glaucoma are contraindicated; or 2) the response to such subsidised agents is inadequate; or 3) the patient cannot tolerate such subsidised agents.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2012 (continued)

178 Standard Formulae SODIUM CHLORIDE ORAL LIQUID Sodium chloride inj 23.4%, 20ml qs Water qs (Only funded if prescribed for treatment of hyponatraemia)

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 June 2012

52 69 METOPROLOL SUCCINATE ( subsidy) ❋ Tab long-acting 23.75 mg ........................................................ 0.96 (2.18) ❋ Tab long-acting 47.5 mg ......................................................... 1.41 (2.74) ❋ Tab long-acting 95 mg ............................................................ 2.42 (4.71) ❋ Tab long-acting 190 mg ............................................................ 4.66 (8.51) ETHINYLOESTRADIOL WITH LEVONORGESTREL ( subsidy) ❋ Tab 30 µg with levonorgestrel 150 µg and 7 inert tab – Up to 84 tab available on a PSO .......................................... 2.45 (6.62) (14.49) (16.50) 73 155 DEXAMETHASONE ( subsidy) ❋ Tab 1 mg – Retail pharmacy-Specialist ..................................... 5.87 Up to 30 tab available on a PSO ❋ Tab 4 mg – Retail pharmacy-Specialist ..................................... 8.16 Up to 30 tab available on a PSO 100 100 30 30 30 30 ✔ Myloc CR Betaloc CR ✔ Myloc CR Betaloc CR ✔ Myloc CR Betaloc CR ✔ Myloc CR Betaloc CR

84 Levlen ED Monofeme Nordette 28 Microgynon 30 ED

✔ Douglas ✔ Douglas

MYCOPHENOLATE MOFETIL – Special Authority see SA1041 – Retail pharmacy ( subsidy) Dispensing pharmacy should check which brand to dispense with the prescriber if prescribed generically. Tab 500 mg ........................................................................... 60.00 50 ✔ Myaccord Cap 250 mg ........................................................................... 60.00 100 ✔ Myaccord

Effective 1 May 2012

33 URSODEOXYCHOLIC ACID – Special Authority see SA1188 – Retail pharmacy ( subsidy) Cap 300 mg – For ursodeoxycholic acid oral liquid formulation refer, page 75 ...................................................................... 71.50 100 ✔ Actigall METOPROLOL SUCCINATE ( subsidy) ❋ Tab long-acting 23.75 mg ......................................................... 0.96 ❋ Tab long-acting 47.5 mg .......................................................... 1.41 ❋ Tab long-acting 95 mg .............................................................. 2.42 ❋ Tab long-acting 190 mg ............................................................ 4.66 METOPROLOL TARTRATE ( subsidy) ❋ Tab 50 mg – For metoprolol tartrate oral liquid formulation refer, page 175 .................................................................... 16.00 ❋ Tab 100 mg ............................................................................ 21.00 ❋ Tab long-acting 200 mg ......................................................... 18.00 ❋ Inj 1 mg per ml, 5 ml .............................................................. 24.00 (34.00) 30 30 30 30 ✔ Metoprolol - AFT CR ✔ Metoprolol - AFT CR ✔ Metoprolol - AFT CR ✔ Metoprolol - AFT CR

52 52

100 60 28 5

✔ Lopresor ✔ Lopresor ✔ Slow-Lopresor Betaloc

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturers Price – effective 1 May 2012 (continued)

62 ZINC AND CASTOR OIL ( subsidy) Oint BP ..................................................................................... 3.83 (5.11) CLINDAMYCIN ( subsidy) Cap hydrochloride 150 mg – Maximum of 4 cap per prescription; can be waived by endorsement - Retail pharmacy -Specialist ............................................................................ 9.90 RIZATRIPTAN ( subsidy) Tab orodispersible 10 mg ......................................................... 1.80 (17.56) DOMPERIDONE ( subsidy) ❋ Tab 10 mg – For domperidone oral liquid formulation refer, page 175 ................................................................... 11.99 500 g PSM

16 3

✔ Dalacin C

125

Maxalt Melt

125 154

100

✔ Motilium

OCTREOTIDE (SOMATOSTATIN ANALOGUE) – Special Authority see SA1016 – Retail pharmacy ( subsidy) Inj 50 µg per ml, 1 ml ............................................................. 19.24 5 (25.65) Hospira (43.50) Sandostatin Inj 100 µg per ml, 1 ml ............................................................ 36.38 5 (48.50) Hospira (81.00) Sandostatin Inj 500 µg per ml, 1 ml ......................................................... 131.25 5 (175.00) Hospira (399.00) Sandostatin DORNASE ALFA – Special Authority see SA0611– Retail pharmacy ( subsidy) Nebuliser soln, 2.5 mg per 2.5 ml ampoule ............................ 250.00 6 ACETYLCYSTEINE – Retail pharmacy-Specialist ( subsidy) Inj 200 mg per ml, 10 ml ...................................................... 178.00 10 ✔ Pulmozyme ✔ Martindale Acetylcysteine

164 179

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Brand Name

Effective 1 May 2012

31 KETONE BLOOD BETA-KETONE ELECTRODES – Maximum of 20 strip per prescription Test strip – Not on a BSO .......................................................... 7.07 10 strip OP ✔ Freestyle Optium Ketone Optium Blood Ketone Test Strips BLOOD GLUCOSE DIAGNOSTIC TEST METER – Subsidy by endorsement a) Maximum of 1 meter per prescription b) 1) A diagnostic blood glucose test meter is subsidised for patients who begin insulin or sulphonylurea therapy after 1 March 2005 or is prescribed for a pregnant woman with diabetes. 2) Only one meter per patient. No further prescriptions will be subsidised. The prescription must be endorsed accordingly. Meter ....................................................................................... 9.00 1 ✔ Freestyle Optium Optium Xceed BLOOD GLUCOSE DIAGNOSTIC TEST STRIP The number of test strips available on a prescription is restricted to 50 unless: 1) Prescribed with insulin or a sulphonylurea but are on a different prescription and the prescription is endorsed accordingly; or 2) Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or 3) Prescribed for a pregnant woman with diabetes and endorsed accordingly. SensoCard blood glucose test strips are subsidised only if prescribed for a patient who is severely visually impaired and is using a SensoCard Plus Talking Blood Glucose Monitor. Blood glucose test strips ......................................................... 21.65 50 test OP ✔ Freestyle Optium Optium 5 second test GEMCITABINE HYDROCHLORIDE – PCT only – Specialist – Special Authority see SA1087 Inj 1 g ..................................................................................... 62.50 1 ✔ Gemcitabine Actavis 1000 Inj 200 mg .............................................................................. 12.50 1 ✔ Gemcitabine Actavis 200 SODIUM CROMOGLYCATE Aerosol inhaler, 5 mg per dose CFC-free .................................. 28.07 112 dose OP ✔ Intal Forte CFC Free Vicrom

143

165

Changes to Sole Subsidised Supply

Effective 1 June 2012

For the list of new Sole Subsidised Supply products effective 1 June 2012 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 10-20.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 June 2012

28 CLARITHROMYCIN Tab 500 mg – Subsidy by endorsement ................................... 10.95 14 (23.30) Klamycin a) Maximum of 14 tab per prescription b) Subsidised only if prescribed for helicobacter pylori eradication and prescription is endorsed accordingly. Note: the prescription is considered endorsed if clarithromycin is prescribed in conjunction with a proton pump inhibitor and either amoxycillin or metronidazole. GLYCERYL TRINITRATE ❋ Oral pump spray 400 µg per dose – Up to 250 dose available on a PSO ............................................................................... 4.45 CEFUROXIME SODIUM Inj 750 mg – Maximum of 1 inj per prescription; can be waived by endorsement ..................................................................... 6.96 (10.71)

250 dose OP ✔ Nitrolingual Pumpspray

5 Zinacef

CEFAZOLIN SODIUM – Subsidy by endorsement Only if prescribed for dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 500 mg ............................................................................... 3.99 5 (5.00) Hospira Inj 1 g ....................................................................................... 3.99 5 (8.00) Hospira QUININE SULPHATE ❋ Tab 200 mg ............................................................................ 15.95 (17.20) TEMOZOLOMIDE – Special Authority see SA1063 – Retail pharmacy Cap 5 mg ............................................................................... 16.00 Cap 20 mg ............................................................................. 72.00 Cap 100 mg ......................................................................... 350.00 Cap 250 mg .......................................................................... 820.00 PHARMACY SERVICES – May only be claimed once per patient ❋ Brand switch fee........................................................................ 0.01 The Pharmacode for BSF Lostaar is 2397145 ❋ Brand switch fee........................................................................ 0.01 The Pharmacode for BSF Arrow-Losartan is 2397153 250 Q 200 5 5 5 5 1 fee 1 fee ✔ Temodal ✔ Temodal ✔ Temodal ✔ Temodal ✔ BSF Lostaar ✔ BSF Arrow-Losartan & Hydrochlorothiazide

113 148

173

Effective 1 May 2012

31 38

▲

SODIUM NITROPRUSSIDE – Maximum of 50 strip per prescription ❋ Test strip – Not on a BSO ........................................................ 14.14 CALCIUM CARBONATE ❋ Tab 1.25 g (500 mg elemental).................................................. 6.38 ❋ Tab 1.5 g (600 mg elemental) ................................................... 7.66 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

20 strip OP ✔ Ketostix 250 250 ✔ Calci-Tab 500 ✔ Calci-Tab 600

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 May 2012 (continued)

85 97 173 188 ORNIDAZOLE Tab 500 mg ........................................................................... 12.38 10 ✔ Tiberal ✔ Ethics Ibuprofen ✔ BSF Bicalaccord

IBUPROFEN – Additional subsidy by Special Authority see SA1038 – Retail pharmacy ❋ Tab 200 mg ............................................................................ 12.75 1,000 PHARMACY SERVICES ❋ Brand switch fee ....................................................................... 0.01 The Pharmacode for BSF Bicalaccord is 2397137 1 fee

PAEDIATRIC ORAL FEED 1.5KCAL/ML – Special Authority see SA1100 – Hospital pharmacy [HP3] Liquid (strawberry) .................................................................... 1.60 200 ml OP ✔ NutriniDrink Liquid (vanilla)........................................................................... 1.60 200 ml OP ✔ NutriniDrink PAEDIATRIC ORAL FEED WITH FIBRE 1.5KCAL/ML – Special Authority see SA1100 – Hospital pharmacy [HP3] Liquid (chocolate) ..................................................................... 1.60 200 ml OP ✔ NutriniDrink Multifibre Liquid (strawberry) ................................................................... 1.60 200 ml OP ✔ NutriniDrink Multifibre Liquid (vanilla) .......................................................................... 1.60 200 ml OP ✔ NutriniDrink Multifibre AMINOACID FORMULA WITHOUT PHENYLALANINE – Special Authority see SA1108 – Hospital pharmacy [HP3] Liquid (tropical) ...................................................................... 30.00 250 ml OP ✔ Easiphen AMINOACID FORMULA WITH MINERALS WITHOUT PHENYLALANINE – Special Authority see SA1108 – Retail pharmacy Powder ................................................................................... 23.38 100 g OP ✔ Metabolic Mineral Mixture

188

198 198

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 August 2012

33 URSODEOXYCHOLIC ACID – Special Authority see SA1188 – Retail pharmacy Cap 300 mg – For ursodeoxycholic acid oral liquid formulation refer, page 175 .................................................................... 71.50 100 METOPROLOL TARTRATE ❋ Inj 1 mg per ml, 5 ml .............................................................. 24.00 (34.00) TETRABENAZINE Tab 25 mg ........................................................................... 178.00 RIZATRIPTAN Tab orodispersible 10 mg .......................................................... 1.80 (17.56) 5 Betaloc 112 3 Maxalt Melt ✔ Xenazine 25

✔ Actigall

52 115 125

154

OCTREOTIDE (SOMATOSTATIN ANALOGUE) – Special Authority see SA1016 – Retail pharmacy Inj 50 µg per ml, 1 ml ............................................................. 19.24 5 (25.65) Hospira (43.50) Sandostatin Inj 100 µg per ml, 1 ml ........................................................... 36.38 5 (48.50) Hospira 81.00 Sandostatin Inj 500 µg per ml, 1 ml ......................................................... 131.25 5 (175.00) Hospira (399.00) Sandostatin

Effective 1 September 2012

52 69 METOPROLOL SUCCINATE ❋ Tab long-acting 23.75 mg ........................................................ 0.96 (2.18) ❋ Tab long-acting 47.5 mg .......................................................... 1.41 (2.74) ❋ Tab long-acting 95 mg ............................................................. 2.42 (4.71) ❋ Tab long-acting 190 mg ............................................................ 4.66 (8.51) ETHINYLOESTRADIOL WITH LEVONORGESTREL ❋ Tab 30 µg with levonorgestrel 150 µg and 7 inert tab – Up to 84 tab available on a PSO .............................................. 2.45 (6.62) (14.49) (16.50) 30 30 30 30 ✔ Myloc CR Betaloc CR ✔ Myloc CR Betaloc CR ✔ Myloc CR Betaloc CR ✔ Myloc CR Betaloc CR

84 Levlen ED Monofeme Nordette 28 Microgynon 30 ED

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted – effective 25 November 2012

51 ATENOLOL ❋ Tab 50 mg ............................................................................. 12.36 ❋ Tab 100 mg ........................................................................... 21.46 1,000 1,000 ✔ Atenolol Tablet USP ✔ Atenolol Tablet USP

Effective 1 December 2012

32 33 52 79 82 INSULIN PEN NEEDLES – Maximum of 100 dev per prescription ❋ 29 g x 12.7 mm ...................................................................... 11.75 ❋ 31 g x 5 mm .......................................................................... 11.75 ❋ 31 g x 6 mm .......................................................................... 11.75 ❋ 31 g x 8 mm .......................................................................... 11.75 100 100 100 100 ✔ SC Profi-Fine ✔ SC Profi-Fine ✔ Fine Ject ✔ SC Profi-Fine

INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE – Maximum of 100 dev per prescription ❋ Syringe 0.3 ml with 29 g x 12.7 mm needle ............................ 13.00 100 ✔ DM Ject ❋ Syringe 0.3 ml with 31 g x 8 mm needle ................................. 13.00 100 ✔ DM Ject ❋ Syringe 0.5 ml with 29 g x 12.7 mm needle ............................ 13.00 100 ✔ DM Ject ❋ Syringe 0.5 ml with 31 g x 8 mm needle ................................. 13.00 100 ✔ DM Ject ❋ Syringe 1 ml with 29 g x 12.7 mm needle ............................... 13.00 100 ✔ DM Ject ❋ Syringe 1 ml with 31 g x 8 mm needle .................................... 13.00 100 ✔ DM Ject PROPRANOLOL ❋ Tab 40 mg ................................................................................ 4.65 GESTRINONE – Retail pharmacy-Specialist Cap 2.5 mg .......................................................................... 101.87 AMOXYCILLIN CLAVULANATE Tab amoxycillin 500 mg with potassium clavulanate 125 mg – Up to 30 tab available on a PSO ........................... 26.00 INDOMETHACIN ❋ Suppos 100 mg ...................................................................... 14.50 CLADRIBINE – PCT only – Specialist Inj 2 mg per ml, 5 ml ............................................................. 873.00 100 8 OP ✔ Cardinol ✔ Dimetriose

100 30 1

✔ Synermox ✔ Arthrexin ✔ Litak S29

98 142

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II

Effective 1 June 2012

18 AMOXYCILLIN CLAVULANATE Tab amoxycillin 500 mg with potassium clavulanate 125 mg ... 26.00 Note – Synermox tab to be delisted 1 August 2012 100 Synermox

ATENOLOL Tab 50 mg .............................................................................. 12.36 1, 000 Tab 100 mg ............................................................................ 21.46 1, 000 Note – Atenolol Tablet USP 50 mg and 100 mg to be delisted 25 November 2012 AZITHROMYCIN Grans for oral liq 200 mg per 5 ml ........................................... 13.20 CLADRIBINE Inj 2 mg per ml, 5 ml ............................................................. 873.00 Note – Litak inj 2 mg per ml, 5 ml to be delisted 1 August 2012 DEXAMETHASONE Tab 1 mg – 1% DV Aug-12 to 2015 .......................................... 5.87 Tab 4 mg – 1% DV Aug-12 to 2015 .......................................... 8.16 EPIRUBICIN Inj 2 mg per ml, 25 ml – 1% DV Aug-12 to 2015 ..................... 39.38 15 ml 1

Atenolol Tablet USP Atenolol Tablet USP

19 25

Zithromax Litak

100 100 1

Douglas Douglas

DBL Epirubicin Hydrochloride Inj 2 mg per ml, 50 ml – 1% DV Aug-12 to 2015 ..................... 58.20 1 DBL Epirubicin Hydrochloride Inj 2 mg per ml, 100 ml – 1% DV Aug-12 to 2015 .................. 94.50 1 DBL Epirubicin Hydrochloride Note – Epirubicin Ebewe inj 2 mg per ml, 25 ml, 50 ml and 100 ml to be delisted 1 August 2012 39 INSULIN PEN NEEDLES 29 g × 12.7 mm ..................................................................... 11.75 100 SC Profi-Fine 31 g × 5 mm .......................................................................... 11.75 100 SC Profi-Fine 31 g × 8 mm .......................................................................... 11.75 100 SC Profi-Fine Note – SC Profi-Fine 29g x 12.7 mm, 31g x 5 mm and 31 g x 8 mm to be delisted 1 August 2012 INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE Syringe 0.3 ml with 29 g × 12.7 mm needle .......................... 13.00 100 DM Ject Syringe 0.3 ml with 31 g × 8 mm needle ............................... 13.00 100 DM Ject Syringe 0.5 ml with 29 g × 12.7 mm needle .......................... 13.00 100 DM Ject Syringe 0.5 ml with 31 g × 8 mm needle ............................... 13.00 100 DM Ject Syringe 1 ml with 29 g × 12.7 mm needle ............................. 13.00 100 DM Ject Syringe 1 ml with 31 g × 8 mm needle .................................. 13.00 100 DM Ject Note – DM Ject syringe 0.3 ml with 29 g x 12.7 mm needle, 0.3 ml with 31 g x 8 mm needle, 0.5 ml with 29 g x 12.7 mm needle, 0.5 ml with 31 g x 8 mm needle, 1 ml with 29 g x 12.7 mm needle and 1 ml with 31 g x 8 mm needle to be delisted 1 August 2012

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 June 2012 (continued)

46 METOPROLOL SUCCINATE ( price) Tab long-acting 23.75 mg ......................................................... 0.96 30 Myloc CR Tab long-acting 47.5 mg ........................................................... 1.41 30 Myloc CR Tab long-acting 95 mg .............................................................. 2.42 30 Myloc CR Tab long-acting 190 mg ............................................................ 4.66 30 Myloc CR Note – Myloc CR tab long acting 23.75 mg, 47.5 mg, 95 mg and 190 mg to be delisted 1 September 2012 MYCOPHENOLATE MOFETIL ( price) Tab 500 mg ........................................................................... 60.00 Cap 250 mg ............................................................................ 60.00 OXALIPLATIN Inj 50 mg – 1% DV Aug-12 to 2015 ........................................ 15.32 Inj 100 mg – 1% DV Aug-12 to 2015 ...................................... 25.01 Note – Oxaliplatin Ebewe inj 50 mg and 100 mg to be delisted 1 August 2012 52 56 60 PARECOXIB Inj 40 mg .............................................................................. 100.00 RECOMBINANT FACTOR VIII Inj 3,000 IU ........................................................................ 3,000.00 SODIUM NITROPRUSSIDE Test strip ................................................................................... 6.00 10 1 50 Dynastat Kogenate FS Accu-Chek Ketur-Test 50 100 1 1 Myaccord Myaccord Oxaliplatin Actavis 50 Oxaliplatin Actavis 100

Effective 1 May 2012

16 ACETYLCYSTEINE ( price and addition of HSS ) Inj 200 mg per ml, 10 ml – 1% DV Jul-12 to 2015................. 178.00 BARIUM SULPHATE (amended brand name) Oral suspension 2.2%, 250 ml .............................................. 175.00 BISOPROLOL FUMARATE Tab 2.5 mg ............................................................................... 3.88 Tab 5 mg .................................................................................. 4.74 Tab 10 mg ................................................................................ 9.18 BLOOD GLUCOSE DIAGNOSTIC TEST METER Meter ....................................................................................... 9.00 BLOOD GLUCOSE DIAGNOSTIC TEST STRIP Blood glucose test strips ........................................................ 21.65 10 Martindale Acetylcysteine CP Plus+ CT Plus+ Bosvate Bosvate Bosvate Freestyle Optium Optium Xceed Freestyle Optium Optium 5 second test

30 30 30 1

50 test

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 May 2012 (continued)

21 BRIMONIDINE TARTRATE Eye drops 0.2% – 1% DV Jul-12 to 2014 .................................. 6.45 Note – AFT brimonidine tartrate eye drops 0.2% to be delisted 1 July 2012 DORNASE ALFA Nebuliser soln, 2.5 mg per 2.5 ml amp .................................. 250.00 KETONE BLOOD BETA-KETONE ELECTRODES Test strips ................................................................................. 7.07 5 ml Arrow-Brimonidine

29 40

6 10 strip

Pulmozyme Freestyle Optium Ketone Optium Blood Ketone Test Strips

METOPROLOL SUCCINATE ( price and addition of HSS) Tab long-acting 23.75 mg – 1% DV Sep-12 to 2015 ................. 0.96 30 Metoprolol - AFT CR Tab long-acting 47.5 mg – 1% DV Sep-12 to 2015 ................... 1.41 30 Metoprolol - AFT CR Tab long-acting 95 mg – 1% DV Sep-12 to 2015 ...................... 2.42 30 Metoprolol - AFT CR Tab long-acting 190 mg – 1% DV Sep-12 to 2015 .................... 4.66 30 Metoprolol - AFT CR Note – Betaloc CR and Myloc CR tab long-acting 23.75 mg, 47.5 mg, 95 mg & 190 mg to be delisted 1 September 2012 METOPROLOL TARTRATE Tab 50 mg – 1% DV Aug-12 to 2015 ...................................... 16.00 Tab 100 mg – 1% DV Aug-12 to 2015 .................................... 21.00 METOPROLOL TARTRATE ( price) Tab long-acting 200 mg – 1% DV Aug-12 to 2015 .................. 18.00 PROPYLTHIOURACIL Tab 50 mg .............................................................................. 35.00 SALBUTAMOL (HSS suspended) Oral liq 2 mg per 5 ml – 1% DV Sep-10 to 2013 ......................... 1.99 TETRABENAZINE Tab 25 mg – 1% DV Jul 12 to 2015 ...................................... 178.00 100 60 28 100 150 ml 112 Lopresor Lopresor Slow-Lopresor PTU Salapin Motetis

46 55 58 62

Effective 1 April 2012

17 AMINO ACID FORMULA Powder (vanilla) ...................................................................... 56.00 Powder (unflavoured) .............................................................. 56.00 AMINOACID FORMULA WITHOUT PHENYLALANINE Liquid (berry) .......................................................................... 13.10 Liquid (orange) ........................................................................ 13.10 Liquid (unflavoured) ................................................................ 13.10 400 g 400 g 125 ml 125 ml 125 ml Neocate Advance Neocate Gold PKU Anamix Junior LQ PKU Anamix Junior LQ PKU Anamix Junior LQ

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 April 2012 (continued)

23 CEFACLOR MONOHYDRATE Cap 250 mg ............................................................................ 24.57 Note: Cefaclor Sandoz cap 250 mg to be delisted 1 June 2012 DABIGATRAN Cap 110 mg. ......................................................................... 148.00 Cap 150 mg ......................................................................... 148.00 Note: This is a new listing of blister packed capsules. New pharmacode. ENTERAL FEED 1.5 KCAL/ML Liquid ........................................................................................ 7.00 ENTERAL FEED 2 KCAL/ML Liquid ........................................................................................ 5.50 FLUDARABINE PHOSPHATE Tab 10 mg – 1% DV Jun-12 to 2015 ..................................... 433.50 100 Ranbaxy-Cefaclor

60 60

Pradaxa Pradaxa

30 30 33 37

1,000 ml 500 ml 20

Nutrison Energy Nutrison Concentrated Fludara Oral

HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATE Powder (vanilla) ...................................................................... 35.50 300 g KetoCal LAPATINIB DITOSYLATE Tab 250 mg ....................................................................... 1,899.00 PROPRANOLOL Tab 10 mg ............................................................................... 3.65 Tab 40 mg ............................................................................... 4.65 PAEDIATRIC ENTERAL FEED WITH FIBRE 0.75 KCAL/ML Liquid ........................................................................................ 4.00 PAEDIATRIC ENTERAL FEED WITH FIBRE 1.5KCAL/ML Liquid ........................................................................................ 6.00 PAZOPANIB Tab 200 mg ....................................................................... 1,334.70 Tab 400 mg ....................................................................... 2,669.40 PRAMIPEXOLE HYDROCHLORIDE Tab 0.125 mg – 1% DV Jun-12 to 2013 .................................... 1.95 Tab 0.25 mg – 1% DV Jun-12 to 2013 ...................................... 2.40 Tab 0.5 mg ............................................................................... 4.20 70 100 100 500 ml Tykerb Apo-Propranolol Apo-Propranolol Nutrini Low Energy Multi Fibre Nutrini Energy Multi Fibre Votrient Votrient Dr Reddy’s Pramipexole Dr Reddy’s Pramipexole Dr Reddy’s Pramipexole

41 51

500 ml

30 30 30 30 30

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 April 2012 (continued)

54 PRASUGREL Tab 5 mg .............................................................................. 108.00 Tab 10 mg ............................................................................ 120.00 PREMATURE BIRTH FORMULA Powder ..................................................................................... 0.75 PRETERM POST-DISCHARGE INFANT FORMULA Powder ................................................................................... 15.25 28 28 100 ml 400 g Effient Effient S26LBW Gold RTF S-26 Gold Premgro

54 54 60

STANDARD SUPPLEMENT ORAL FEED (POWDER) 1.0KCAL/ML (amended chemical name) Powder (chocolate) ................................................................... 9.50 900 g Ensure 10.22 Sustagen Hospital Formula Powder (vanilla) ........................................................................ 9.50 900 g Ensure 10.22 Sustagen Hospital Formula STANDARD SUPPLEMENT ORAL FEED (POWDER) (new listing) Powder (vanilla) ........................................................................ 9.50 TRIAMCINOLONE ACETONIDE ( price and addition of HSS) Inj 10 mg per ml, 1 ml – 1% DV Jun-12 to 2014...................... 21.90 Inj 40 mg per ml, 1 ml – 1% DV Jun-12 to 2014 ..................... 53.79 900 g 5 5 Fortisip Kenacort-A Kenacort-A40

60 63

Section H changes to Part III

Effective 1 June 2012

68 INDOMETHACIN Supp 100 mg S29 For any indication approved by the hospital service

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

Index

Pharmaceuticals and brands A Accu-Chek Ketur-Test .................................. 21, 38 Actigall .............................................................. 30 Acetazolamide ................................................... 27 Acetylcysteine.............................................. 31, 38 Actigall .............................................................. 35 Alendronate sodium ........................................... 25 Alendronate sodium with cholecalciferol ............. 25 Alfacalcidol ........................................................ 23 Aluminium hydroxide.......................................... 23 Alu-Tab .............................................................. 23 Amino acid formula ............................................ 39 Aminoacid formula with minerals without phenylalanine .................................................. 34 Aminoacid formula without phenylalanine ..... 34, 39 Amoxycillin clavulanate ................................ 36, 37 Anastrozole ........................................................ 26 Apo-Clopidogrel ................................................. 23 Apo-Moclobemide.............................................. 25 Apo-Propranolol ................................................. 40 Aremed .............................................................. 26 Arimidex ............................................................ 26 Aromasin ........................................................... 26 Arrow-Brimonidine ................................. 21, 28, 39 Arrow-Meloxicam............................................... 25 Arrow-Sertraline ................................................. 25 Arthrexin ............................................................ 36 Atenolol ....................................................... 36, 37 Atenolol Tablet USP...................................... 36, 37 Auranofin ........................................................... 21 Ava 30 ED.......................................................... 24 Azithromycin ................................................ 21, 37 Azopt ................................................................. 27 B Barium sulphate ................................................. 38 Batrafen ............................................................. 26 Betaloc ........................................................ 30, 35 Betaloc CR ................................................... 30, 35 Bimatoprost ....................................................... 28 Bisoprolol fumarate ...................................... 21, 38 Blood glucose diagnostic test meter ............. 32, 38 Blood glucose diagnostic test strip ............... 32, 38 Bosvate ....................................................... 21, 38 Brimonidine tartrate ................................ 21, 28, 39 Brimonidine tartrate with timolol maleate............. 28 Brinzolamide ...................................................... 27 BSF Arrow-Losartan & Hydrochlorothiazide ........ 33 BSF Bicalaccord ................................................. 34 BSF Lostaar ....................................................... 33 C Calci-Tab 500 .................................................... 33 Calci-Tab 600 .................................................... 33 Calcium carbonate ............................................. 33 Carboplatin ........................................................ 22 Cardinol ............................................................. 36 Carvedilol ........................................................... 24 Cefaclor monohydrate ........................................ 40 Cefazolin sodium ............................................... 33 Cefuroxime sodium ............................................ 33 Cholvastin .......................................................... 24 Ciclopirox olamine.............................................. 26 Ciclopiroxolamine............................................... 26 Cladribine..................................................... 36, 37 Clarithromycin.................................................... 33 Clindamycin ....................................................... 31 Clopidogrel ........................................................ 23 Combigan .......................................................... 28 Cosopt ............................................................... 28 CP Plus+ .......................................................... 38 CT Plus+ .......................................................... 38 D Dabigatran ......................................................... 40 Dalacin C ........................................................... 31 DBL Carboplatin ................................................. 22 DBL Doxorubicin ................................................ 22 DBL Epirubicin Hydrochloride ....................... 21, 37 Dexamethasone ........................................... 30, 37 Diamox .............................................................. 27 Dilatrend ............................................................ 24 Dimetriose ......................................................... 36 DM Ject ....................................................... 36, 37 Domperidone ..................................................... 31 Dornase alfa................................................. 31, 39 Dorzolamide hydrochloride ................................. 27 Dorzolamide hydrochloride with timolol maleate.. 28 Doxorubicin ....................................................... 22 DP-Anastrozole .................................................. 26 Dr Reddy’s Ondansetron .................................... 26 Dr Reddy’s Pramipexole ..................................... 40 Dr Reddy’s Terbinafine ....................................... 25 Dynastat ............................................................ 38 Dynacirc-SRO .................................................... 24 E Easiphen ............................................................ 34 Effient .......................................................... 23, 41 Ensure ............................................................... 41 Enteral feed 1.5 Kcal/ml ..................................... 40 Enteral feed 2 kcal/ml ......................................... 40 Epirubicin..................................................... 21, 37 Escitalopram ...................................................... 25 Ethics Ibuprofen ................................................. 34 Ethinyloestradiol with levonorgestrel ....... 24, 30, 35 Evista................................................................. 25 Exemestane ....................................................... 26

Index

Pharmaceuticals and brands F Ferro-F-Tabs ...................................................... 23 Ferro-tab ............................................................ 23 Ferrous fumarate ................................................ 23 Ferrous fumarate with folic acid .......................... 23 Ferrum H............................................................ 23 Finasteride ......................................................... 24 Fine Ject ............................................................ 36 Fludarabine phosphate ....................................... 40 Fludara Oral ....................................................... 40 Fortisip .............................................................. 41 Fosamax ............................................................ 25 Fosamax Plus .................................................... 25 Freestyle Optium .......................................... 32, 38 Freestyle Optium Ketone ............................... 32, 39 G Gemcitabine Actavis 200.............................. 26, 32 Gemcitabine Actavis 1000............................ 26, 32 Gemcitabine Actavis s29 .............................. 26, 32 Gemcitabine hydrochloride ........................... 26, 32 Gemfibrozil ........................................................ 24 Gestrinone ......................................................... 36 Glyceryl trinitrate ................................................ 33 H High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate ................................................... 40 Hysite ................................................................ 28 I Ibuprofen ........................................................... 34 Indomethacin ............................................... 36, 41 Insulin pen needles....................................... 36, 37 Insulin syringes, disposable with attached needle ......................................... 36, 37 Intal Forte CFC Free ............................................ 32 Iron polymaltose ................................................ 23 Isradipine ........................................................... 24 K Kenacort-A......................................................... 41 Kenacort-A40..................................................... 41 KetoCal .............................................................. 40 Ketone blood beta-ketone electrodes ............ 32, 39 Ketostix.............................................................. 33 Klamycin............................................................ 33 Kogenate FS....................................................... 38 L Lapatinib ditosylate ...................................... 27, 40 Latanoprost........................................................ 28 Letara ................................................................ 26 Letrozole ............................................................ 26 Levlen ED .............................................. 24, 30, 35 Lipazil ................................................................ 24 Litak ............................................................ 36, 37 Lopresor ...................................................... 30, 39 Loxalate ............................................................. 25 Loxamine ........................................................... 25 Lumigan ............................................................ 28 M Magnesium sulphate .......................................... 23 Martindale Acetylcysteine ............................. 31, 38 Maxalt Melt .................................................. 31, 35 Meloxicam ......................................................... 25 Metabolic Mineral Mixture................................... 34 Metoprolol - AFT CR..................................... 30, 39 Metoprolol succinate ....................... 30, 35, 38, 39 Metoprolol tartrate .................................. 30, 35, 39 Microgynon 30 ED ................................. 24, 30, 35 Moclobemide ..................................................... 25 Monofeme ............................................. 24, 30, 35 Motetis .............................................................. 39 Motilium ............................................................ 31 Multivitamins ..................................................... 23 Myaccord .................................................... 30, 38 Mycophenolate mofetil ................................. 30, 38 Myloc CR ............................................... 30, 35, 38 N Nardil ................................................................. 25 Neocate Advance ............................................... 39 Neocate Gold ..................................................... 39 NeuroKare.......................................................... 23 Nitrolingual Pumpspray ...................................... 33 Nordette 28 ............................................ 24, 30, 35 NutriniDrink ........................................................ 34 NutriniDrink Multifibre ......................................... 34 Nutrini Energy Multi Fibre.................................... 40 Nutrini Low Energy Multi Fibre ............................ 40 Nutrison Concentrated ........................................ 40 Nutrison Energy ................................................. 40 O Octreotide (somatostatin analogue) .............. 31, 35 Ondansetron ...................................................... 26 One-Alpha .......................................................... 23 Optium 5 second test ................................... 32, 38 Optium Blood Ketone Test Strips .................. 32, 39 Optium Xceed .............................................. 32, 38 Ornidazole.......................................................... 34 Oxaliplatin Actavis 50 ................................... 21, 38 Oxaliplatin Actavis 100 ................................. 21, 38 Oxaliplatin .................................................... 21, 38 P Paediatric enteral feed with fibre 0.75 Kcal/ml..... 40 Paediatric enteral feed with fibre 1.5Kcal/ml........ 40 Paediatric oral feed 1.5Kcal/ml ........................... 34 Paediatric oral feed with fibre 1.5Kcal/ml ............ 34

Index

Pharmaceuticals and brands Paediatric Seravit ............................................... 23 Parecoxib........................................................... 38 Parnate .............................................................. 25 Paroxetine hydrochloride .................................... 25 Pazopanib .......................................................... 40 Pharmacy services....................................... 33, 34 Phenelzine sulphate............................................ 25 Pioglitazone ....................................................... 23 Pizaccord........................................................... 23 PKU Anamix Junior LQ ....................................... 39 Potassium iodate ............................................... 23 Pradaxa ............................................................. 40 Pramipexole hydrochloride ................................. 40 Prasugrel ..................................................... 23, 41 Pravastatin ......................................................... 24 Premature birth formula...................................... 41 Preterm post-discharge infant formula ................ 41 Propranolol .................................................. 36, 40 Propylthiouracil ............................................ 21, 39 PTU ............................................................. 21, 39 Pulmozyme .................................................. 31, 39 Q Q 200 ................................................................ 33 Quinine sulphate ................................................ 33 R Raloxifene hydrochloride .................................... 25 Ranbaxy-Cefaclor............................................... 40 Recombinant factor VIII ...................................... 38 Ridaura S29 ....................................................... 21 Rizatriptan.................................................... 31, 35 S S-26 Gold Premgro ............................................ 41 S26LBW Gold RTF ............................................. 41 Salapin .............................................................. 39 Salbutamol................................................... 22, 39 Sandostatin .................................................. 31, 35 SC Profi-Fine................................................ 36, 37 Sertraline ........................................................... 25 Slow-Lopresor ............................................. 30, 39 Sodium chloride ................................................. 26 Sodium chloride oral liquid ................................. 29 Sodium cromoglycate ........................................ 32 Sodium fluoride .................................................. 23 Sodium nitroprusside ............................. 21, 33, 38 Standard supplement oral feed (powder) ............ 41 Sunitinib ............................................................ 26 Sustagen hospital formula .................................. 41 Sutent ................................................................ 26 Synermox .................................................... 36, 37 T Tamsulosin hydrochloride .................................. 24 Tamsulosin-Rex ................................................. 24 Temodal ............................................................ 33 Temozolomide ................................................... 33 Terbinafine ......................................................... 25 Tetrabenazine............................................... 35, 39 Tiberal ............................................................... 34 Tranylcypromine sulphate .................................. 25 Travatan............................................................. 28 Travoprost ......................................................... 28 Triamcinolone acetonide .................................... 41 Trusopt .............................................................. 27 Tykerb ......................................................... 27, 40 U Ursodeoxycholic acid ................................... 30, 35 V Ventolin ............................................................. 22 Vicrom ............................................................... 32 Vitadol C ............................................................ 23 Vitamin A with vitamins D and C ......................... 23 Votrient .............................................................. 40 X Xenazine 25 ....................................................... 35 Z Zinacef ............................................................... 33 Zinc and castor oil ........................................ 24, 31 Zithromax..................................................... 21, 37

Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

If Undelivered, Return To: PO Box 10-254, Wellington 6143, New Zealand

Metadata

Title

Schedule Update - effective 1 June 2012

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 June 2012 Cumulative for May and June 2012 Section H cumulative for April, May and June 2012 Only annually for hard copy Schedule and Updates $55 www. schedule. co.nz today…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.